info-graphics-peopleThe Alliance for Heart Failure
was established in September 2015. A coalition of charities, patient groups, professional bodies and healthcare companies, its purpose is to raise the profile of heart failure in Government, the NHS and the media and improve outcomes for people with heart failure.

Members of the Alliance collaborate on overarching policy issues with the aim of securing prioritisation of heart failure and extending access to existing first-class care, treatment and services from the NHS to make it available to everyone with heart failure.

Objectives for 2024

The Alliance is focusing on four core strategic objectives in 2024:

  1. Highlight the variation in uptake of NT-ProBNP tests in primary care and Community Diagnostic Centres by gathering data and engaging with national stakeholders.
  2. Showcase the new revenue opportunities available to community pharmacies by engaging with national stakeholders and member organisations.
  3. Continue to support key stakeholders with the drive to encourage adoption of NICE guidelines and recognised pathways.
  4. Develop grassroots support through ongoing communication and engagement with heart failure professionals across the breadth of provider services.

The Alliance for Heart Failure will continue to focus driving change based on the ten recommendations in our Heart Failure: A Call to Action report.

Read our latest update.


Membership of the Alliance for Heart Failure is open to charities, patient groups, professional bodies, public sector organisations and corporate members across the UK with an interest in heart failure.

Individual members remain independent, but the shared mission to deliver timely diagnosis and improve access to the right care and support is strengthened by joining forces and through collaboration.

Current Alliance for Heart Failure member organisations are:

Steering Group

The Alliance is a coalition of member organisations, and the Steering Group comprises individuals from these member organisations.

There are two Co-chairs to the Steering Group, appointed on a 12 month rolling tenure.  Current Co-chairs are:

  • Preeti Minhas, Assistant Director of Clinical Learning, Education for Health – appointed December 2023
  • Richard Corder, Past President at Cardiovascular Care Partnership – appointed December 2023


The Alliance is supported and funded by AstraZeneca UK, Boehringer Ingelheim Limited, Medtronic UK Ltd, Novartis Pharmaceuticals UK Ltd, and Roche Diagnostics Ltd.